GW Pharma shares rocket
following trial
following trial
The experimental drug epidiolex has yet again been successful in treating children with epilespsy and if the US approve its use it will be the first ever prescription medicine that contains cannabis.
The company's shares rose as much as 16 percent to hit a record high of 811 pence on the London Stock Exchange. They were trading 10 percent higher at 770p by 1255 GMT.
read the article in full here - http://uk.reuters.com/article/us-gw-pharma-study-idUKKCN11W15Q
S
Soft Secrets